Factors Influencing Immunotherapy Outcomes in Cancer: Sarcopenia and Systemic Inflammation.
作者信息
Ucgul Enes
机构信息
Division of Endocrinology and Metabolism, Etlik City Hospital, Ankara, Turkey.
出版信息
Cancer Control. 2025 Jan-Dec;32:10732748251318393. doi: 10.1177/10732748251318393.
Abstract
摘要
相似文献
1
Factors Influencing Immunotherapy Outcomes in Cancer: Sarcopenia and Systemic Inflammation.
Cancer Control. 2025 Jan-Dec;32:10732748251318393. doi: 10.1177/10732748251318393.
2
Factors Influencing Immunotherapy Outcomes in Cancer: Sarcopenia and Systemic Inflammation.
Cancer Control. 2024 Jan-Dec;31:10732748241302248. doi: 10.1177/10732748241302248.
3
Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy.
Oncologist. 2020 Mar;25(3):e528-e535. doi: 10.1634/theoncologist.2019-0751. Epub 2019 Dec 5.
4
Factors Influencing Immunotherapy Outcomes in Cancer: Sarcopenia and Systemic Inflammation.
Cancer Control. 2025 Jan-Dec;32:10732748251318390. doi: 10.1177/10732748251318390.
5
Contribution of skeletal muscle to cancer immunotherapy: A focus on muscle function, inflammation, and microbiota.
Nutrition. 2023 Jan;105:111829. doi: 10.1016/j.nut.2022.111829. Epub 2022 Aug 21.
6
Effects of nutritional indices and inflammatory parameters on patients received immunotherapy for non-small cell lung cancer.
Curr Probl Cancer. 2024 Feb;48:101035. doi: 10.1016/j.currproblcancer.2023.101035. Epub 2023 Nov 20.
7
Preoperative sarcopenia and systemic immune-inflammation index can predict response to intravesical Bacillus Calmette-Guerin instillation in patients with non-muscle invasive bladder cancer.
Front Immunol. 2022 Oct 7;13:1032907. doi: 10.3389/fimmu.2022.1032907. eCollection 2022.
8
The role of sarcopenia in pre- and postoperative inflammation: implications of outcomes in patients with colorectal cancer.
J Gastrointest Surg. 2024 Nov;28(11):1791-1798. doi: 10.1016/j.gassur.2024.08.015. Epub 2024 Aug 21.
9
Association Between Systemic Inflammation and Malnutrition With Survival in Patients With Cancer Sarcopenia-A Prospective Multicenter Study.
Front Nutr. 2022 Feb 7;8:811288. doi: 10.3389/fnut.2021.811288. eCollection 2021.
10
Sarcopenia accompanied by systemic inflammation can predict clinical outcomes in patients with head and neck cancer undergoing curative therapy.
Front Oncol. 2024 Mar 14;14:1378762. doi: 10.3389/fonc.2024.1378762. eCollection 2024.
本文引用的文献
1
Factors Influencing Immunotherapy Outcomes in Cancer: Sarcopenia and Systemic Inflammation.
Cancer Control. 2024 Jan-Dec;31:10732748241302248. doi: 10.1177/10732748241302248.
2
Sarcopenia in cancer: Risking more than muscle loss.
Tech Innov Patient Support Radiat Oncol. 2020 Nov 9;16:50-57. doi: 10.1016/j.tipsro.2020.10.001. eCollection 2020 Dec.
3
Sarcopenia: revised European consensus on definition and diagnosis.
Age Ageing. 2019 Jul 1;48(4):601. doi: 10.1093/ageing/afz046.
4
Prognostic Significance of CT-Determined Sarcopenia in Patients with Small-Cell Lung Cancer.
J Thorac Oncol. 2015 Dec;10(12):1795-9. doi: 10.1097/JTO.0000000000000690.
Zotero 插件